Skip to main content
. Author manuscript; available in PMC: 2009 Nov 5.
Published in final edited form as: JAMA. 2007 Feb 7;297(5):480–488. doi: 10.1001/jama.297.5.480

Table 1.

Annual sales for the cohort included in this analysis and for all drugs submitted 2002–2004

Annual Sales Estimate ($) This cohort (N=9) 2002–2004 cohort (N=59)
> 1,000,000,000 5/9 (55.6%) 13/59 (22%)
200,000,000–1,000,000,000 3/9 (33%) 28/59 (47%)
<200,000,000 1/9 (11%) 18/59 (31%)